Literature DB >> 25010259

Health related quality of life in people with advanced chronic liver disease.

James G Orr1, Tara Homer2, Laura Ternent2, Julia Newton1, Calum J McNeil1, Mark Hudson1, David E J Jones3.   

Abstract

Cirrhosis has a long natural history with considerable symptomatic impacts, particularly in advancing disease. Measuring health related quality of life (HRQOL) in liver disease provides detail about the nature and extent of its effects on individuals. Understanding the drivers of impaired HRQOL can help identify targets for improvement through new treatments or health systems service delivery. Evaluation of novel therapies which target symptomatic improvement, should be done with suitable outcome measures, including HRQOL assessment. In this article, we provide an overview of HRQOL in advanced liver disease for the clinician. A clear description of the important HRQOL tools is given alongside a discussion of the factors, which are known to contribute to impaired HRQOL in advanced liver disease.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Health related quality of life; Liver; Quality of life

Mesh:

Year:  2014        PMID: 25010259     DOI: 10.1016/j.jhep.2014.06.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.

Authors:  Nicolas Weiss; Matteo Rosselli; Sarah Mouri; Damien Galanaud; Louis Puybasset; Banwari Agarwal; Dominique Thabut; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2016-10-11       Impact factor: 3.584

Review 2.  From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients.

Authors:  Fredrik Åberg
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

3.  Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention.

Authors:  Benjamin E Hudson; Kelly Ameneshoa; Anya Gopfert; Rachael Goddard; Karen Forbes; Julia Verne; Peter Collins; Fiona Gordon; Andrew J Portal; Colette Reid; C Anne McCune
Journal:  Frontline Gastroenterol       Date:  2016-10-05

4.  Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.

Authors:  Maria Stepanova; Fatema Nader; Christophe Bureau; Danielle Adebayo; Laure Elkrief; Dominique Valla; Markus Peck-Radosavljevic; Anne McCune; Victor Vargas; Macarena Simon-Talero; Juan Cordoba; Paolo Angeli; Silvia Rossi; Stewart MacDonald; Jeroen Capel; Rajiv Jalan; Zobair M Younossi
Journal:  Qual Life Res       Date:  2018-02-19       Impact factor: 4.147

5.  Psychiatric Comorbidity, Health-Related Quality of Life, and Mental Health Service Utilization Among Patients Awaiting Liver Transplant.

Authors:  Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon
Journal:  J Pain Symptom Manage       Date:  2018-03-08       Impact factor: 3.612

Review 6.  Where are we going? Translational research in hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Kevin Mullen; James G Orr; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2015-09-09       Impact factor: 3.584

7.  Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease.

Authors:  Nneka N Ufere; David L O'Riordan; Kara E Bischoff; Angela K Marks; Nwamaka Eneanya; Raymond T Chung; Vicki Jackson; Steven Z Pantilat; Areej El-Jawahri
Journal:  J Pain Symptom Manage       Date:  2019-07-19       Impact factor: 3.612

8.  Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.

Authors:  Myrte K Neijenhuis; Tom J G Gevers; Marie C Hogan; Patrick S Kamath; Titus F M Wijnands; Ralf C P M van den Ouweland; Marie E Edwards; Jeff A Sloan; Wietske Kievit; Joost P H Drenth
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

9.  Health-promoting behaviors benefit the mental health of cirrhotic outpatients.

Authors:  Hui-Chuan Huang; Kuan-Chia Lin; Chia-Shin Wu; Nae-Fang Miao; Ming-Yao Chen
Journal:  Qual Life Res       Date:  2018-02-27       Impact factor: 4.147

10.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.